Search research articles
Contact Us
Filters
Showing results (41-50 of 67) with videos related to
Page
of 7
Sort By:
European Cytokine Network
|
October 1, 1990
TNF alpha enhancement of NK and LAK cell functions induced by high-dose IL-2 in human peripheral blood mononuclear cells from patients pretreated with alpha IFN + IL-2
M Favrot, V Combaret, J Y Blay, et al.
Cancer Research
|
April 15, 1990
Correlation between clinical response to interleukin 2 therapy and sustained production of tumor necrosis factor
J Y Blay, M C Favrot, S Negrier, et al.
Cancer Treatment Reviews
|
June 1, 1989
Interleukin-2 with and without LAK cells in metastatic renal cell carcinoma: the Lyon first-year experience in 20 patients
T Philip, A Mercatello, S Negrier, et al.
Medical and Pediatric Oncology
|
October 23, 1997
False positive MIBG scan
D Frappaz, F Giammarile, P Thiesse, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 1995
Clinical application of retroviral gene transfer in oncology: results of a French study with tumor-infiltrating lymphocytes transduced with the gene of resistance to neomycin
Y Merrouche, S Negrier, C Bain, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1993
Indication and limits of megatherapy and bone marrow transplantation in high-risk neuroblastoma: a single centre analysis of prognostic factors
R Ladenstein, M Favrot, C Lasset, et al.
European Journal of Cancer & Clinical Oncology
|
November 1, 1989
Clinical value of N-myc oncogene amplification in 52 patients with neuroblastoma included in recent therapeutic protocols
V Combaret, Q Wang, M C Favrot, et al.
Nouvelle Revue Francaise D'Hematologie
|
January 1, 1989
Analysis of parameters for maximal in vitro proliferation and activation of lymphokine-activated killer cells (LAK)
C Coze, V Combaret, I Philip, et al.
Bulletin Du Cancer
|
March 1, 1996
[Unusual relapse for neuroblastoma. Case of an intracranial relapse]
D Frappaz, P Marec Bérard, V Combaret, et al.
British Journal of Cancer
|
January 1, 1997
Clinical relevance of TRKA expression on neuroblastoma: comparison with N-MYC amplification and CD44 expression
V Combaret, N Gross, C Lasset, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 67) with videos related to
Sort By:
Page
of 7
European Cytokine Network
|
October 1, 1990
TNF alpha enhancement of NK and LAK cell functions induced by high-dose IL-2 in human peripheral blood mononuclear cells from patients pretreated with alpha IFN + IL-2
M Favrot, V Combaret, J Y Blay, et al.
Cancer Research
|
April 15, 1990
Correlation between clinical response to interleukin 2 therapy and sustained production of tumor necrosis factor
J Y Blay, M C Favrot, S Negrier, et al.
Cancer Treatment Reviews
|
June 1, 1989
Interleukin-2 with and without LAK cells in metastatic renal cell carcinoma: the Lyon first-year experience in 20 patients
T Philip, A Mercatello, S Negrier, et al.
Medical and Pediatric Oncology
|
October 23, 1997
False positive MIBG scan
D Frappaz, F Giammarile, P Thiesse, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 1995
Clinical application of retroviral gene transfer in oncology: results of a French study with tumor-infiltrating lymphocytes transduced with the gene of resistance to neomycin
Y Merrouche, S Negrier, C Bain, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1993
Indication and limits of megatherapy and bone marrow transplantation in high-risk neuroblastoma: a single centre analysis of prognostic factors
R Ladenstein, M Favrot, C Lasset, et al.
European Journal of Cancer & Clinical Oncology
|
November 1, 1989
Clinical value of N-myc oncogene amplification in 52 patients with neuroblastoma included in recent therapeutic protocols
V Combaret, Q Wang, M C Favrot, et al.
Nouvelle Revue Francaise D'Hematologie
|
January 1, 1989
Analysis of parameters for maximal in vitro proliferation and activation of lymphokine-activated killer cells (LAK)
C Coze, V Combaret, I Philip, et al.
Bulletin Du Cancer
|
March 1, 1996
[Unusual relapse for neuroblastoma. Case of an intracranial relapse]
D Frappaz, P Marec Bérard, V Combaret, et al.
British Journal of Cancer
|
January 1, 1997
Clinical relevance of TRKA expression on neuroblastoma: comparison with N-MYC amplification and CD44 expression
V Combaret, N Gross, C Lasset, et al.
Page
of 7